Case Study: Global Biopharmaceutical Company achieves $300M revenue potential with Clarify Health

Optimize drug uptake at launch, and track market evolution using deep, longitudinal patient and physician insights

A Global Biopharmaceutical Company partnered with Clarify Health to better understand a rare hematological disease ahead of launch for a novel targeted therapy. Using Clarify Growth, the company needed to identify the patient profiles most likely to receive and benefit from the drug, track how those profiles might shift as competing treatments entered the market, and quantify the opportunity at both national and physician levels.

Clarify Health used Clarify Growth to create and dynamically refresh a composite patient profile based on disease history, provider attributes, and treatment patterns, then mapped those patients to physicians and scored opportunity by panel composition and therapy behavior. The analysis identified about 14,000 “look-alike” patients not currently on therapy, around 120 physicians with sizable target cohorts, and an estimated $300M in additional revenue potential, helping shape a more targeted commercial strategy.